Innovative Cellular Therapeutics Appoints Lucy Lu as Chief Operations Officer
ROCKVILLE, Md., April 06, 2022 (GLOBE NEWSWIRE) — Innovative Cellular Therapeutics (ICT), a clinical stage…
News
Alimera Exhibits Continued Growth and Expansion With New Branding and Office Relocation
ATLANTA, April 06, 2022 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global…
Cabaletta Bio to Present at the 21st Annual Needham Virtual Healthcare Conference
PHILADELPHIA, April 06, 2022 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology…
Mereo BioPharma to Participate in Fireside Chat at the 21st Annual Needham Virtual Healthcare Conference
LONDON and REDWOOD CITY, Calif., April 06, 2022 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc…
Innovative Cellular Therapeutics Appoints Robert Dallimore as SVP of Quality & Compliance
ROCKVILLE, Md., April 06, 2022 (GLOBE NEWSWIRE) — Innovative Cellular Therapeutics (ICT), a clinical stage…
Rhythm Pharmaceuticals Optimizes Design of EMANATE and DAYBREAK Clinical Trials to Advance Setmelanotide for Rare Genetic Diseases of Obesity
– Phase 3 EMANATE trial to focus on rare patient populations with highest likelihood for…
Arcutis Completes Enrollment in ARRECTOR Pivotal Phase 3 Trial of Topical Roflumilast Foam in Scalp and Body Psoriasis
Topline data anticipated in late Q3/early Q4 A total of 432 subjects are enrolled in…
Applied Molecular Transport Appoints Charlene Banard to its Board of Directors
SOUTH SAN FRANCISCO, Calif., April 06, 2022 (GLOBE NEWSWIRE) — Applied Molecular Transport Inc. (Nasdaq:…
Avadel Pharmaceuticals Announces Publication of Positive Secondary Endpoint Data from Pivotal Phase 3 REST-ON Trial
Once-at-bedtime FT218 demonstrated clinically meaningful improvement in assessments of disrupted nighttime sleep compared to placebo…
Ocuphire Pharma to Present at Wet AMD & DME Drug Development Summit in Boston, MA
FARMINGTON HILLS, Mich., April 06, 2022 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a…
BetterLife’s BETR-001 Demonstrates BETR-001 Anti-depressant Activity in Preclinical Models of Depression
VANCOUVER, British Columbia, April 06, 2022 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
PepGen Announces First Participant Dosed in a Phase 1 Clinical Trial of PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy
– Initiation of Phase 1 Study Marks PepGen’s Transition to a Clinical Stage Company –…
Morphic Therapeutic Expands Leadership with Key Appointments in Clinical and Corporate Development
Dr. Brihad Abhyankar named Vice President of Clinical Development, deeply experienced GI drug development leaderAaron…
Collegium Appoints Neil McFarlane to its Board of Directors
STOUGHTON, Mass., April 06, 2022 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading,…
Evaxion Biotech Hosting Key Opinion Leader Webinar on Metastatic Melanoma and Personalized Cancer Immunotherapies
Tuesday, April 12th @ 12:30 pm ET COPENHAGEN, Denmark, April 06, 2022 (GLOBE NEWSWIRE) —…
Context Therapeutics® to Participate in Two April 2022 Investor Conferences
PHILADELPHIA, April 06, 2022 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq:…
TG Therapeutics Announces Oral Presentation of Data from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis at the American Academy of Neurology Annual Meeting
NEW YORK, April 06, 2022 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that data…
OpGen’s subsidiary Ares Genetics provides update on collaboration agreement to drive cutting-edge digital solutions in global fight against antimicrobial resistance (AMR)
Extended existing master services agreement with Sandoz, to develop digital platform for development and life…
Inozyme Pharma to Present at the 21st Annual Needham Virtual Healthcare Conference
BOSTON, April 06, 2022 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage biopharmaceutical…
Cognition Therapeutics Announces Participation in 21st Annual Needham Virtual Healthcare Conference
PURCHASE, N.Y., April 06, 2022 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical…